Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.
Olalla J, Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J.
BMC Pharmacol Toxicol. 2018 Oct 10;19(1):63. doi: 10.1186/s40360-018-0252-z.
Similar articles
Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.
Escribano Montaner A, García de Lomas J, Villa Asensi JR, Asensio de la Cruz O, de la Serna Blázquez O, Santiago Burruchaga M, Mondéjar López P, Torrent Vernetta A, Feng Y, Van Dyke MK, Reyes J, Garcia-Corbeira P, Talarico CA; EPI-Strep-064 study group.
Eur J Pediatr. 2018 Feb;177(2):181-192. doi: 10.1007/s00431-017-3044-3. Epub 2017 Dec 29.
The Arctic Ocean as a dead end for floating plastics in the North Atlantic branch of the Thermohaline Circulation.
Cózar A, Martí E, Duarte CM, García-de-Lomas J, van Sebille E, Ballatore TJ, Eguíluz VM, González-Gordillo JI, Pedrotti ML, Echevarría F, Troublè R, Irigoien X.
Sci Adv. 2017 Apr 19;3(4):e1600582. doi: 10.1126/sciadv.1600582. eCollection 2017 Apr.
Seroprevalence of pertussis amongst healthcare professionals in Spain.
Rodríguez de la Pinta ML, Castro Lareo MI, Ramon Torrell JM, García de Lomas J, Devadiga R, Reyes J, McCoig C, Tafalla M, García-Corbeira P.
Vaccine. 2016 Feb 17;34(8):1109-14. doi: 10.1016/j.vaccine.2015.12.036. Epub 2015 Dec 22.
Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J, Weinke T, Garcia de Lomas J, Meyer CU, Bertrand I, Eymin C, Thomas S, Sadorge C.
Vaccine. 2015 Feb 4;33(6):789-95. doi: 10.1016/j.vaccine.2014.12.024. Epub 2014 Dec 30.
Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.
Puig-Barberà J, García-de-Lomas J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Limón-Ramírez R, Pérez-Vilar S, Micó-Esparza JL, Tortajada-Girbés M, Carratalá-Munuera C, Larrea-González R, Beltrán-Garrido JM, Otero-Reigada Mdel C, Mollar-Maseres J, Correcher-Medina P, Schwarz-Chavarri G, Gil-Guillén V; Valencia Hospital Network for the Study of Influenza and Respiratory Virus Disease.
PLoS One. 2014 Nov 13;9(11):e112294. doi: 10.1371/journal.pone.0112294. eCollection 2014.
Plastic debris in the open ocean.
Cózar A, Echevarría F, González-Gordillo JI, Irigoien X, Ubeda B, Hernández-León S, Palma AT, Navarro S, García-de-Lomas J, Ruiz A, Fernández-de-Puelles ML, Duarte CM.
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10239-44. doi: 10.1073/pnas.1314705111. Epub 2014 Jun 30.
Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients.
Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, Hidalgo C, Faura A, Montero M, García de Lomas J, Horcajada JP, Puig JM, Pascual J.
Clin J Am Soc Nephrol. 2011 Sep;6(9):2208-14. doi: 10.2215/CJN.02160311. Epub 2011 Aug 18.
Becton Dickinson Directigen EZ Flu A+B assay in the diagnosis of pandemic influenza A H1N1 2009 virus infection in adult patients.
Nogueira JM, Alberola J, Alcaraz MJ, García de Lomas J, Navarro D.
Influenza Other Respir Viruses. 2011 May;5(3):146-7. doi: 10.1111/j.1750-2659.2010.00194.x. Epub 2011 Jan 25. No abstract available.
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob Agents Chemother. 2010 Jul;54(7):2953-9. doi: 10.1128/AAC.01548-09. Epub 2010 May 3.
beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.
Lerma M, Cebrián L, Giménez M, Coronel P, Gimeno M, Aguilar L, García de Lomas J.
Rev Esp Quimioter. 2008 Sep;21(3):149-52.
Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide.
García-de-Lomas J, Lerma M, Cebrián L, Esteban E, Giménez MJ, Aguilar L, Domínguez V, Randez JJ.
J Hosp Infect. 2008 Mar;68(3):248-54. doi: 10.1016/j.jhin.2007.12.011. Epub 2008 Mar 4.
Increasing telithromycin resistance among Streptococcus pyogenes in Europe.
Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.
J Antimicrob Chemother. 2008 Mar;61(3):603-11. doi: 10.1093/jac/dkm525. Epub 2008 Jan 24.
Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for E. coli Urinary Pathogens.
Rev Esp Quimioter. 2007 Jun;20(2):206-10.
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.
Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV.
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):485-90.
Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens.
Rev Esp Quimioter. 2007 Mar;20(1):68-76.
Nitrate stimulation of indigenous nitrate-reducing, sulfide-oxidising bacterial community in wastewater anaerobic biofilms.
Garcia-de-Lomas J, Corzo A, Carmen Portillo M, Gonzalez JM, Andrades JA, Saiz-Jimenez C, Garcia-Robledo E.
Water Res. 2007 Jul;41(14):3121-31. Epub 2007 May 23.
Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins.
García-de-Lomas J, Lerma M, Cebrián L, Juan-Bañón JL, Coronel P, Giménez MJ, Aguilar L.
Int J Antimicrob Agents. 2007 Aug;30(2):190-2. Epub 2007 Apr 25. No abstract available.
The Meropenem Yearly Susceptibility Test Information Collection antimicrobial susceptibility program in Spain: a 5-year analysis.
Pascual A, Perea E, Alvarez M, Casal M, Garcia de Lomas J, Garcia Rodríguez JA, Martin R, Soria G, Zapardiel J; Spanish MYSTIC group.
Diagn Microbiol Infect Dis. 2007 Feb;57(2):195-200. Epub 2006 Oct 18.
Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM, Molina J, Naberan K, Esteban E, Herreras A, Garcia-de-Lomas J.
Int J Antimicrob Agents. 2006 Nov;28(5):472-6.
Etiological misidentification by routine biochemical tests of bacteremia caused by Gordonia terrae infection in the course of an episode of acute cholecystitis.
Gil-Sande E, Brun-Otero M, Campo-Cerecedo F, Esteban E, Aguilar L, García-de-Lomas J.
J Clin Microbiol. 2006 Jul;44(7):2645-7.
Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
Navarro D, Escribano A, Cebrián L, Gimeno C, García-Maset L, García-de-Lomas J; Spanish Pneumococcal Infection Study Network.
Clin Vaccine Immunol. 2006 Jun;13(6):665-70.
Nitrate promotes biological oxidation of sulfide in wastewaters: experiment at plant-scale.
García de Lomas J, Corzo A, Gonzalez JM, Andrades JA, Iglesias E, Montero MJ.
Biotechnol Bioeng. 2006 Mar 5;93(4):801-11.
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain.
Pérez-Trallero E, García-de-la-Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob Agents Chemother. 2005 May;49(5):1965-72.
Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain.
Albertí S, García-Rey C, García-Laorden MI, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.
J Clin Microbiol. 2005 Mar;43(3):1433-6.
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
Beekmann SE, Heilmann KP, Richter SS, García-de-Lomas J, Doern GV; GRASP Study Group.
Int J Antimicrob Agents. 2005 Feb;25(2):148-56.
Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection.
Navarro D, García-Maset L, Gimeno C, Escribano A, García-de-Lomas J; Spanish Pneumococcal Infection Study Network.
J Clin Microbiol. 2004 Oct;42(10):4853-5.
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain.
García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, Baquero F; Spanish Surveillance Group for Respiratory Pathogens.
Int J Antimicrob Agents. 2003 Nov;22(5):541-4.
Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project.
García-De-Lomas J, García-Rey C, López L, Gimeno C.
J Antimicrob Chemother. 2002 Dec;50 Suppl S2:21-6.
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin.
Latorre C, García-Rey C, García-Perea A, Perea E, Aguilar L, Cercenado E, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.
J Antimicrob Chemother. 2002 Aug;50(2):301-3. No abstract available.
Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain.
Pérez-Trallero E, García-Rey C, Martín-Sánchez AM, Aguilar L, García-de-Lomas J, Ruiz J; Spanish Surveillance Group for Respiratory Pathogens (SAUCE Program).
Antimicrob Agents Chemother. 2002 Aug;46(8):2665-7.
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.
Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, Baquero F; Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40.
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.
Marco F, García-de-Lomas J, García-Rey C, Bouza E, Aguilar L, Fernández-Mazarrasa C; Spanish Surveillance Group for Respiratory Pathogens.
Antimicrob Agents Chemother. 2001 Nov;45(11):3226-8.
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens.
Marco F, Bouza E, García-de-Lomas J, Aguilar L.
J Antimicrob Chemother. 2000 Oct;46(4):557-64.
Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a 1-year (1996-97) multicenter surveillance study. Spanish Surveillance Group for Respiratory Pathogens.
García-Rodríguez JA, Baquero F, García de Lomas J, Aguilar L.
Infection. 1999;27(4-5):265-7.
Immunological diagnosis of human hydatid cyst relapse: utility of the enzyme-linked immunoelectrotransfer blot and discriminant analysis.
Gadea I, Ayala G, Diago MT, Cuñat A, Garcia de Lomas J.
Clin Diagn Lab Immunol. 2000 Jul;7(4):549-52.
Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.
García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J.
Vaccine. 2000 Apr 28;18(21):2173-6.
A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.
Dal-Ré R, García-Corbeira P, García-de-Lomas J.
J Med Virol. 2000 Apr;60(4):363-6.
Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.
García-Corbeira P, Hogrefe W, Aguilar L, García-de-Lomas J, Gil A, Bayas JM, Vilella A, Dal-Ré R.
J Med Virol. 1999 Dec;59(4):502-6.
Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens.
Gómez-Lus R, Granizo JJ, Aguilar L, Bouza E, Gutierrez A, García-de-Lomas J.
J Clin Microbiol. 1999 Oct;37(10):3384-6.
Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population?
García-Corbeira P, Dal-Ré R, Aguilar L, Granizo JJ, García-de-Lomas J.
J Med Virol. 1999 Oct;59(2):194-7.
[Accreditation and certification of laboratories of clinical microbiology? Yes, but are ENAC and AENOR adequate?].
García de Lomas J, Farga A, Gimeno C.
Enferm Infecc Microbiol Clin. 1999 Mar;17(3):111-2. Spanish. No abstract available.
Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study.
García-Corbeira P, Dal-Ré R, García-de-Lomas J, Aguilar L.
Vaccine. 1999 Apr 9;17(15-16):1978-82.
[Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
García de Lomas J, Gimeno C, Díez J, Bermejo M, Navarro D, García-Ponte L.
Enferm Infecc Microbiol Clin. 1999 Jan;17(1):24-8. Spanish.
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.
Baquero F, García-Rodríguez JA, García de Lomas J, Aguilar L.
Antimicrob Agents Chemother. 1999 Feb;43(2):357-9.
[Initial empirical antibiotic treatment of community-acquired pneumonia].
Frías J, Gomis M, Prieto J, Mensa J, Bouza E, García-Rodríguez JA, Torres A, Dorca J, Zalacaín R, García de Lomas J.
Rev Esp Quimioter. 1998 Sep;11(3):255-61. Review. Spanish. No abstract available.
A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs.
García-de-Lomas J, Millás E, Lázaro MA, Bermejo M, Gimeno C, Navarro D, Sánchez S.
Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):420-3.
[The current epidemiologic situation and resistance of respiratory pathogens in Spain].
García de Lomas J.
Med Clin (Barc). 1998 Feb;110 Suppl 1:44-51. Spanish. No abstract available.
In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
Gimeno C, Borja J, Navarro D, Valdés L, García-Barbal J, García-de-Lomas J.
Chemotherapy. 1998 Mar-Apr;44(2):94-8.
[Penetration of meropenem in gram-negative bacilli. Differences in activity with imipenem].
García de Lomas J, Navarro D, Gimeno C.
Enferm Infecc Microbiol Clin. 1997 Sep;15 Suppl 1:14-9. Spanish.
Filters: Manage Filters